SCOPUS 정보 검색 플랫폼

Volumn 4, Issue 10, 2015, Pages

Therapeutic potential of interleukin-27 against cancers in preclinical mouse models

(7) Mizoguchi, Izuru a Chiba, Yukino a Furusawa, Jun Ichi a Xu, Mingli a Tsunoda, Ren a Higuchi, Kaname a Yoshimoto, Takayuki a

a TOKYO MEDICAL UNIVERSITY (Japan)

Author keywords

antitumor; IL 27; poly(I:C); TLR3; TRAIL

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; INTERLEUKIN 10; INTERLEUKIN 27; POLYINOSINIC POLYCYTIDYLIC ACID; PROGRAMMED DEATH 1 LIGAND 1; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FOLLICULAR LYMPHOMA; HUMAN; IMMUNE RESPONSE; LARGE CELL LYMPHOMA; MOUSE MODEL; NATURAL KILLER CELL; NON SMALL CELL LUNG CANCER; NONHUMAN; PROSTATE CANCER; REGULATORY T LYMPHOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 84940706532 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.1080/2162402X.2015.1042200 Document Type: Article

Times cited : (4)

References (10)

1
- 84940655753
- Interleukin-27: regulation of immune responses and disease development by a pleiotropic cytokine with pro- and anti-inflammatory properties
- Yoshimoto T., Yoshimoto T., (eds), Tokyo: Springer
- I.Mizoguchi, K.Higuchi, K.Mitobe, R.Tsunoda, J.Mizuguchi, T.Yoshimoto (2013) Interleukin-27: regulation of immune responses and disease development by a pleiotropic cytokine with pro- and anti-inflammatory properties. In: T.Yoshimoto, T.Yoshimoto, editors. Cytokine Frontiers: Regulation of Immune Responses in Health and Disease. Tokyo: Springer. pp. 353-75
- (2013) Cytokine Frontiers: Regulation of Immune Responses in Health and Disease , pp. 353-375
- Mizoguchi, I.¹ Higuchi, K.² Mitobe, K.³ Tsunoda, R.⁴ Mizuguchi, J.⁵ Yoshimoto, T.⁶

2
- 0842347431
- Potent antitumor activity of interleukin-27
- 14871851
- M.Hisada, S.Kamiya, K.Fujita, M.L.Belladonna, T.Aoki, Y.Koyanagi, J.Mizuguchi, T.Yoshimoto. Potent antitumor activity of interleukin-27. Cancer Res 2004; 64:1152-6; PMID:14871851; http://dx.doi.org/10.1158/0008-5472.CAN-03-2084
- (2004) Cancer Res , vol.64 , pp. 1152-1156
- Hisada, M.¹ Kamiya, S.² Fujita, K.³ Belladonna, M.L.⁴ Aoki, T.⁵ Koyanagi, Y.⁶ Mizuguchi, J.⁷ Yoshimoto, T.⁸

3
- 33745685864
- Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma
- 16778218
- S.Oniki, H.Nagai, T.Horikawa, J.Furukawa, M.L.Belladonna, T.Yoshimoto, I.Hara, C.Nishigori. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res 2006; 66:6395-404; PMID:16778218; http://dx.doi.org/10.1158/0008-5472.CAN-05-4087
- (2006) Cancer Res , vol.66 , pp. 6395-6404
- Oniki, S.¹ Nagai, H.² Horikawa, T.³ Furukawa, J.⁴ Belladonna, M.L.⁵ Yoshimoto, T.⁶ Hara, I.⁷ Nishigori, C.⁸

4
- 84924268722
- Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
- ; 6:3694-708; PMID: 25638163
- I.Airoldi, M.G.Tupone, S.Esposito, M.V.Russo, G.Barbarito, G.Cipollone, E.Di Carlo. Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer. Oncotarget 2015; 6:3694-708; PMID: 25638163
- (2015) Oncotarget
- Airoldi, I.¹ Tupone, M.G.² Esposito, S.³ Russo, M.V.⁴ Barbarito, G.⁵ Cipollone, G.⁶ Di Carlo, E.⁷

5
- 33744909098
- Antiangiogenic and antitumor activities of IL-27
- 16751375
- M.Shimizu, M.Shimamura, T.Owaki, M.Asakawa, K.Fujita, M.Kudo, Y.Iwakura, Y.Takeda, A.D.Luster, J.Mizuguchi et al. Antiangiogenic and antitumor activities of IL-27. J Immunol 2006; 176:7317-24; PMID:16751375; http://dx.doi.org/10.4049/jimmunol.176.12.7317
- (2006) J Immunol , vol.176 , pp. 7317-7324
- Shimizu, M.¹ Shimamura, M.² Owaki, T.³ Asakawa, M.⁴ Fujita, K.⁵ Kudo, M.⁶ Iwakura, Y.⁷ Takeda, Y.⁸ Luster, A.D.⁹ Mizuguchi, J.¹⁰

6
- 77955720345
- Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma
- 20587591
- C.Cocco, N.Giuliani, E.Di Carlo, E.Ognio, P.Storti, M.Abeltino, C.Sorrentino, M.Ponzoni, D.Ribatti, I.Airoldi. Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma. Clin Cancer Res 2010; 16:4188-97; PMID:20587591; http://dx.doi.org/10.1158/1078-0432.CCR-10-0173
- (2010) Clin Cancer Res , vol.16 , pp. 4188-4197
- Cocco, C.¹ Giuliani, N.² Di Carlo, E.³ Ognio, E.⁴ Storti, P.⁵ Abeltino, M.⁶ Sorrentino, C.⁷ Ponzoni, M.⁸ Ribatti, D.⁹ Airoldi, I.¹⁰

7
- 84885416680
- IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner
- 24155891
- Y.Chiba, I.Mizoguchi, K.Mitobe, K.Higuchi, H.Nagai, C.Nishigori, J.Mizuguchi, T.Yoshimoto. IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner. PLoS One 2013; 8:e76159; PMID:24155891; http://dx.doi.org/10.1371/journal.pone.0076159
- (2013) PLoS One , vol.8 , pp. e76159
- Chiba, Y.¹ Mizoguchi, I.² Mitobe, K.³ Higuchi, K.⁴ Nagai, H.⁵ Nishigori, C.⁶ Mizuguchi, J.⁷ Yoshimoto, T.⁸

8
- 84874846166
- Interleukin-27 signaling promotes immunity against endogenously arising murine tumors
- 23554861
- K.D.Natividad, S.R.Junankar, N.Mohd Redzwan, R.Nair, R.C.Wirasinha, C.King, R.Brink, A.Swarbrick, M.Batten. Interleukin-27 signaling promotes immunity against endogenously arising murine tumors. PLoS One 2013; 8:e57469; PMID:23554861; http://dx.doi.org/10.1371/journal.pone.0057469
- (2013) PLoS One , vol.8 , pp. e57469
- Natividad, K.D.¹ Junankar, S.R.² Mohd Redzwan, N.³ Nair, R.⁴ Wirasinha, R.C.⁵ King, C.⁶ Brink, R.⁷ Swarbrick, A.⁸ Batten, M.⁹

9
- 84899804081
- A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells
- PMID: 24443555
- S.Xia, J.Wei, J.Wang, H.Sun, W.Zheng, Y.Li, Y.Sun, H.Zhao, S.Zhang, T.Wen et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol 2014; PMID: 24443555; http://www.jleukbio.org/content/95/5/733.long
- (2014) J Leukoc Biol
- Xia, S.¹ Wei, J.² Wang, J.³ Sun, H.⁴ Zheng, W.⁵ Li, Y.⁶ Sun, Y.⁷ Zhao, H.⁸ Zhang, S.⁹ Wen, T.¹⁰

10
- 84873745745
- IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells
- 23225163
- Z.Liu, J.Q.Liu, F.Talebian, L.C.Wu, S.Li, X.F.Bai. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. Eur J Immunol 2013; 43:468-79; PMID:23225163; http://dx.doi.org/10.1002/eji.201242930
- (2013) Eur J Immunol , vol.43 , pp. 468-479
- Liu, Z.¹ Liu, J.Q.² Talebian, F.³ Wu, L.C.⁴ Li, S.⁵ Bai, X.F.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.